{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:19:04Z","timestamp":1774541944655,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":5406,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s12603-009-0059-0","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T17:25:26Z","timestamp":1258046726000},"page":"205-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Evolution of A\u03b242 and A\u03b240 levels and A\u03b242\/A\u03b240 ratio in plasma during progression of Alzheimer's disease: A multicenter assessment"],"prefix":"10.1016","volume":"13","author":[{"given":"K.","family":"Blennow","sequence":"first","affiliation":[]},{"given":"G.","family":"De Meyer","sequence":"additional","affiliation":[]},{"given":"O.","family":"Hansson","sequence":"additional","affiliation":[]},{"given":"L.","family":"Minthon","sequence":"additional","affiliation":[]},{"given":"A.","family":"Wallin","sequence":"additional","affiliation":[]},{"given":"H.","family":"Zetterberg","sequence":"additional","affiliation":[]},{"given":"P.","family":"Lewczuk","sequence":"additional","affiliation":[]},{"given":"H.","family":"Vanderstichele","sequence":"additional","affiliation":[]},{"given":"E.","family":"Vanmechelen","sequence":"additional","affiliation":[]},{"given":"J.","family":"Kornhuber","sequence":"additional","affiliation":[]},{"given":"J.","family":"Wiltfang","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"3","key":"10.1007\/s12603-009-0059-0_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1007\/s12603-009-0059-0_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/15622970701535502","article-title":"Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature","volume":"9","author":"Diniz","year":"2007","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"10.1007\/s12603-009-0059-0_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.neurobiolaging.2007.02.016","article-title":"Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia","volume":"29","author":"Engelborghs","year":"2007","journal-title":"Neurobiol Aging"},{"issue":"16","key":"10.1007\/s12603-009-0059-0_bib4","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased beta-amyloid1\u201342 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1007\/s12603-009-0059-0_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S1474-4422(06)70503-8","article-title":"Plasma Abeta in Alzheimer's disease\u2014up or down?","volume":"5","author":"Zetterberg","year":"2006","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1007\/s12603-009-0059-0_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S1474-4422(06)70611-1","article-title":"Plasma amyloid-beta concentrations in Alzheimer's disease: an alternative hypothesis","volume":"5","author":"Fullwood","year":"2006","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1007\/s12603-009-0059-0_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S1474-4422(06)70612-3","article-title":"Plasma amyloid-beta concentrations in Alzheimer's disease: an alternative hypothesis","volume":"5","author":"Oprisiu","year":"2006","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1007\/s12603-009-0059-0_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1212\/01.wnl.0000278386.00035.21","article-title":"Plasma amyloid ta protein is elevated in late-onset Alzheimer disease families","volume":"70","author":"Ertekin-Taner","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s12603-009-0059-0_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","article-title":"Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease","volume":"64","author":"Graff-Radford","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1007\/s12603-009-0059-0_bib10","unstructured":"Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E et al. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging 2008; in press."},{"key":"10.1007\/s12603-009-0059-0_bib11","unstructured":"Kornhuber J, Schmidtke K, Frolich L, Perneczky R, Wolf S, Hampel H et al. Early and differential diagnosis of dementia and MCI: design and cohort baseline characteristics of the German Competence Net Dementias. Dementia Geriatr. Cogn. Disorders in press."},{"issue":"11","key":"10.1007\/s12603-009-0059-0_bib12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/jnnp.2004.050385","article-title":"The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition","volume":"76","author":"Nordlund","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1007\/s12603-009-0059-0_bib13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00702-006-0511-9","article-title":"The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics","volume":"113","author":"Lewczuk","year":"2006","journal-title":"J Neural Transm"},{"issue":"6","key":"10.1007\/s12603-009-0059-0_bib14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.neurobiolaging.2006.12.010","article-title":"Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study","volume":"29","author":"Lewczuk","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.1007\/s12603-009-0059-0_bib15","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neurobiolaging.2006.05.006","article-title":"CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment","volume":"28","author":"Bouwman","year":"2007","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1007\/s12603-009-0059-0_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1007\/s12603-009-0059-0_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.03.064","article-title":"Longitudinal stability of CSF biomarkers in Alzheimer's disease","volume":"419","author":"Blennow","year":"2007","journal-title":"Neurosci Lett"},{"issue":"10","key":"10.1007\/s12603-009-0059-0_bib18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/01.wnl.0000271375.37131.04","article-title":"Longitudinal changes of CSF biomarkers in memory clinic patients","volume":"69","author":"Bouwman","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s12603-009-0059-0_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JAD-2007-12307","article-title":"Intraindividual stability of CSF biomarkers for Alzheimer's disease over two years","volume":"12","author":"Zetterberg","year":"2007","journal-title":"J Alzheimers Dis"},{"issue":"1\u20132","key":"10.1007\/s12603-009-0059-0_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/JMN:23:1-2:115","article-title":"Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature","volume":"23","author":"Lewczuk","year":"2004","journal-title":"J Mol Neurosci"},{"issue":"8","key":"10.1007\/s12603-009-0059-0_bib21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1\u201340) and Abeta(1\u201342) and the risk of dementia: a prospective case-cohort study","volume":"5","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1007\/s12603-009-0059-0_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainres.2008.02.060","article-title":"Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls","volume":"1219","author":"Xu","year":"2008","journal-title":"Brain Res"},{"issue":"37","key":"10.1007\/s12603-009-0059-0_bib23","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1073\/pnas.0805902105","article-title":"Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease","volume":"105","author":"Schupf","year":"2008","journal-title":"Proc Nat Acad Sci"},{"issue":"2\u20133","key":"10.1007\/s12603-009-0059-0_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2007.09.058","article-title":"The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels","volume":"428","author":"Abdullah","year":"2007","journal-title":"Neurosci Lett"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-009-0059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12603-009-0059-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723022807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723022807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-009-0059-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:05:10Z","timestamp":1761138310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723022807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1279770723022807"],"URL":"https:\/\/doi.org\/10.1007\/s12603-009-0059-0","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of A\u03b242 and A\u03b240 levels and A\u03b242\/A\u03b240 ratio in plasma during progression of Alzheimer's disease: A multicenter assessment","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12603-009-0059-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}